Switching from vitamin K antagonists to direct oral anticoagulants: Treatment satisfaction and patient concerns.
Myrthe M A TooropNienke van ReinMelchior C NiermanHelga W VermaasMenno V HuismanFelix J M van der MeerSuzanne C CannegieterWillem M LijferingPublished in: Journal of thrombosis and haemostasis : JTH (2020)
DOAC treatment satisfaction was high. A substantial number of patients expressed concerns about adverse events, especially women, patients aged < 60 years, or highly educated patients. Our findings among patients who already had switched to DOAC may assist in the process of shared decision-making when switching a patient from VKA to DOAC is considered.